Glycerin

Product NDC: 46122-221
11-digit product format: 461220221
Labeler code: 46122
Product ID: 46122-221_4147d1ac-9ee0-6442-e063-6294a90a576f
Type: HUMAN OTC DRUG
Nonproprietary name: Glycerin
Dosage form: SUPPOSITORY
Route: RECTAL
Labeler: Amerisource Bergen/Good Neighbor Pharmacy
Application: M007
Marketing category: OTC MONOGRAPH DRUG
Marketing start: 2013-09-12
Substance: GLYCERIN
Active strength: 2.1 g/1
Pharmacologic classes: Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 21 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	46122-221-63	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	46122-221-71	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	46122-221-63	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	46122-221-71	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	46122-221-63	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	46122-221-71	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	46122-221-63	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	46122-221-71	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	46122-221-71	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	46122-221-63	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	46122-221-71	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	46122-221-63	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	46122-221-71	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	46122-221-63	U	Excluded because listing certification expired	`0efc9e666f02…`	`f202fb6c5f17…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Glycerin
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
GLYCERIN	2.1 g/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
PDC6A3C0OX	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
583084	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
e6a8914f-cfd9-4c72-abaa-22189bf0faef	Available on FDA.report

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
46122-221-63	2025-07-02	GNP Glycerin Supp.
46122-221-63	2025-07-02	GNP Glycerin Supp.
46122-221-71	2025-07-02	GNP Glycerin Supp.
46122-221-71	2025-07-02	GNP Glycerin Supp.
46122-221-63	2025-01-30	GNP Glycerin Supp.
46122-221-63	2025-01-30	GNP Glycerin Supp.
46122-221-71	2025-01-30	GNP Glycerin Supp.
46122-221-71	2025-01-30	GNP Glycerin Supp.

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
46122-221-63	Glycerin	25 in 1 JAR	SUPPOSITORY	25		11
46122-221-71	Glycerin	50 in 1 JAR	SUPPOSITORY	50		11

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
46122-221-63	EA - Each	46122-221	ef78bcd7-30bc-4df8-b7e5-bd3e8eb0978c	1	2013-10-17
46122-221-71	EA - Each	46122-221	12ac563a-74be-4ff3-8d4d-a32a1c803335	1	2013-10-17

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
46122-221	GLYCERIN (GLYCERIN) SUPPOSITORY [AMERISOURCE BERGEN/GOOD NEIGHBOR PHARMACY]	8	Current NDC, Legacy NDC, 2 package rows	20231209_e6a8914f-cfd9-4c72-abaa-22189bf0faef.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 5 of 42 · 833 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
MILK OF MAGNESIA MINT	MAGNESIUM HYDROXIDE	Preferred Pharmaceuticals Inc.	f8bba8cb-a111-4285-8bdb-2273a049c3bb	2026-07-08	Warnings	Exact identifier application number: M007
DOCUSATE SODIUM, EXTRA STRENGTH 250 MG	DOCUSATE SODIUM	Advanced Rx LLC	fc8cf24e-8ca1-b3fb-e053-6294a90a7a50	2026-07-06	Warnings	Exact identifier application number: M007
Curewell Docusate Sodium Liquid	DOCUSATE SODIUM.50MG/5ML	RMT HEALTH LLC	55903043-2a1d-0525-e063-6394a90ae182	2026-07-01	Warnings	Exact identifier application number: M007
Senna	SENNOSIDES 8.6 MG TABLETS	Aarkish Pharmaceuticals NJ Inc.	564bc9a5-13b5-4cce-a349-6b2e122683ed	2026-07-01	Warnings	Exact identifier application number: M007
Senna-S	DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG	Aarkish Pharmaceuticals NJ Inc.	faca8f3e-d9eb-44c5-93ab-f59ed1c0f56f	2026-07-01	Warnings	Exact identifier application number: M007
ENEMEEZ	DOCUSATE SODIUM	Quest Products, LLC	0b06445d-0839-497e-bdff-e0fe224a7738	2026-06-30	Warnings	Exact identifier application number: M007
ENEMEEZ Plus	DOCUSATE SODIUM AND BENZOCAINE	Quest Products, LLC	1670ca59-7275-4ac6-bef4-674a7b24c7b3	2026-06-30	Warnings	Exact identifier application number: M007
Mineral oil	MINERAL OIL	CVS Pharmacy, Inc.	1183bcbc-51ec-e53a-e063-6394a90af0f2	2026-06-26	Warnings, Adverse reactions	Exact identifier application number: M007
Glycerin	GLYCERIN	Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd	552d9018-cc7d-7e1a-e063-6294a90a3322	2026-06-26	Warnings	Exact identifier application number: M007
Glycerin	GLYCERIN	Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd	552e16b9-f46a-7838-e063-6394a90ab8aa	2026-06-26	Warnings	Exact identifier application number: M007
Walgreens Gentle Laxative	BISACODYL SUPPOSITORY	Walgreens	20c43036-830b-0e1d-e063-6394a90adf5f	2026-06-25	Warnings	Exact identifier application number: M007
Docusate Sodium	DOCUSATE SODIUM	American Health Packaging	be7cab51-ce7e-465d-95db-083e69288cfd	2026-06-25	Warnings	Exact identifier application number: M007
Epsom Salt	MAGNESIUM SULFATE	Vi-Jon, LLC	ba490c22-19f0-4887-9509-bd3d32e0f5b1	2026-06-24	Warnings, Adverse reactions	Exact identifier application number: M007
MILK OF MAGNESIA	MAGNESIUM HYDROXIDE	KROGER COMPANY	a1b0c638-6c34-1b72-e053-2995a90acc85	2026-06-24	Warnings	Exact identifier application number: M007
Womens Laxative	WOMENS LAXTIVE	Allegiant Health	549a11d1-a096-4c22-96b4-2d4f54f46022	2026-06-24	Warnings	Exact identifier application number: M007
Magnesium Citrate	MAGNESIUM CITRATE	Meijer Distribution Inc	f4259fda-19d4-087e-e053-2995a90a7081	2026-06-22	Warnings	Exact identifier application number: M007
STOOL SOFTENER	DOCUSATE SODIUM	Geri-Care Pharmaceuticals, Corp	3ec42148-6786-22f2-e054-00144ff8d46c	2026-06-18	Warnings	Exact identifier application number: M007
Glycerin	GLYCERIN SUPPOSITORY	Everpharm LLC	546347e5-841e-15ca-e063-6294a90a0c8b	2026-06-16	Warnings	Exact identifier application number: M007
Glycerin	GLYCERIN SUPPOSITORY	Everpharm LLC	5463f869-2b92-4551-e063-6394a90ad6f9	2026-06-16	Warnings	Exact identifier application number: M007
MINICA-S	GLYCERIN	Sato Pharmaceutical Co., Ltd.	687902eb-e702-4e87-a0ce-9add05e3cbc1	2026-06-16	Warnings	Exact identifier application number: M007

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
PDC6A3C0OX	GLYCERIN	56-81-5	GLYCERIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
583084	glycerin 2.1 GM Adult Rectal Suppository	PSN	e6a8914f-cfd9-4c72-abaa-22189bf0faef	11
583084	glycerin 2100 MG Rectal Suppository	SCD	e6a8914f-cfd9-4c72-abaa-22189bf0faef	11
583084	glycerin 2.1 GM Rectal Suppository	SY	e6a8914f-cfd9-4c72-abaa-22189bf0faef	11
583084	glycerin 82.5 % Adult Rectal Suppository	SY	e6a8914f-cfd9-4c72-abaa-22189bf0faef	11
583084	glycerin 2.1 GM Adult Rectal Suppository	PSN	89b5d376-f8c6-4c86-9dd8-67d047d0d45b	1
583084	glycerin 2100 MG Rectal Suppository	SCD	89b5d376-f8c6-4c86-9dd8-67d047d0d45b	1
583084	glycerin 2.1 GM Rectal Suppository	SY	89b5d376-f8c6-4c86-9dd8-67d047d0d45b	1
583084	glycerin 82.5 % Adult Rectal Suppository	SY	89b5d376-f8c6-4c86-9dd8-67d047d0d45b	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
46122-221-63	46122022163	25 SUPPOSITORY in 1 JAR (46122-221-63)	25 suppository	2013-09-12	0000-00-00	No	No	Current
46122-221-71	46122022171	50 SUPPOSITORY in 1 JAR (46122-221-71)	50 suppository	2013-09-12	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Glycerin	Amerisource Bergen/Good Neighbor Pharmacy \| DSC Laboratories Inc.	2025-10-16	HUMAN OTC DRUG LABEL	11
Glycerin	ATLANTIC BIOLOGICALS CORP.	2018-12-19	HUMAN OTC DRUG LABEL	1